Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables: 2020-2024

Historic Receivables for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $163.7 million.

  • Cellebrite DI's Receivables rose 11.17% to $104.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $443.4 million, marking a year-over-year increase of 6.53%. This contributed to the annual value of $163.7 million for FY2024, which is 1.65% down from last year.
  • Latest data reveals that Cellebrite DI reported Receivables of $163.7 million as of FY2024, which was down 1.65% from $166.4 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Receivables ranged from a high of $166.4 million in FY2023 and a low of $100.2 million during FY2020.
  • In the last 3 years, Cellebrite DI's Receivables had a median value of $163.7 million in 2024 and averaged $163.5 million.
  • In the last 5 years, Cellebrite DI's Receivables soared by 39.45% in 2021 and then decreased by 1.65% in 2024.
  • Cellebrite DI's Receivables (Yearly) stood at $100.2 million in 2020, then surged by 39.45% to $139.8 million in 2021, then climbed by 14.69% to $160.3 million in 2022, then climbed by 3.84% to $166.4 million in 2023, then decreased by 1.65% to $163.7 million in 2024.